Fig. 6From: NCAPD2 is a favorable predictor of prognostic and immunotherapeutic biomarker for multiple cancer types including lung cancerRelationship between NCAPD2 expression and cancer stemness, drug sensitivity. (A) Association between NCAPD2 and RNAss, DNAss. (B) Association between NCAPD2 and HRD. (C) Association between NCAPD2 and TMB. (D) Association between NCAPD2 and GDSC, CTRP drug sensitivity (Red indicated a positive correlation, with higher gene expression had greater susceptibility to the drug, while blue indicated the opposite). (E) Correlation between NCAPD2 and CellMiner drug sensitivity (P < 0.05)Back to article page